Attention deficit hyperactivity disorder in adults
- 3 June 2010
- journal article
- review article
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 11 (5) , 684-698
Abstract
Objective. To examine available literature regarding attention deficit hyperactivity disorder (ADHD) in adults. Methods. An electronic literature search of peer-reviewed English language articles using MEDLINE (without time limits) was undertaken. Results. Symptoms of ADHD in adults exert a substantial negative impact on daily life, including work, social life and relationships. Co-morbidities are common, further impairing quality of life. Diagnosis of adult ADHD can be difficult, as current criteria require evidence of symptom onset before the age of 7 years and impact on activities typically undertaken by children. Drug therapy is the first-line treatment for adult ADHD, particularly stimulant medication. However, methylphenidate (MPH) immediate-release tablets require three or more times daily dosing, which can impact on compliance, while demonstrating a loss of symptomatic benefit later in the day. Extended-release preparations of MPH, mixed amphetamine salts and dexamphetamine can provide symptom control for 6–12 h and the non-stimulant atomoxetine has demonstrated benefit in reducing ADHD symptoms. These therapies are generally well tolerated, but may be associated with adverse effects on the cardiovascular system, which need to be further assessed in controlled clinical trials. Psychological therapy may be beneficial in adults who continue to experience clinically significant symptoms while receiving pharmacotherapy. Conclusion. Further research in all areas of adult ADHD is urgently needed.Keywords
This publication has 79 references indexed in Scilit:
- Long-Term Effectiveness and Safety of Dexmethylphenidate Extended-Release Capsules in Adult ADHDJournal of Attention Disorders, 2009
- Structural brain change in Attention Deficit Hyperactivity Disorder identified by meta-analysisBMC Psychiatry, 2008
- Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorderExpert Opinion on Pharmacotherapy, 2008
- The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey InitiativeOccupational and Environmental Medicine, 2008
- Effect of Switching Drug Formulations from Immediate-Release to Extended-Release OROS MethylphenidateCNS Drugs, 2008
- Further Evidence of Dopamine Transporter Dysregulation in ADHD: A Controlled PET Imaging Study Using AltropaneBiological Psychiatry, 2007
- Long-acting medications for the hyperkinetic disordersEuropean Child & Adolescent Psychiatry, 2006
- Effect of methylphenidate formulation on treatment patterns and use of emergency room servicesAmerican Journal of Health-System Pharmacy, 2006
- Cardiovascular Effects of Atomoxetine in Children, Adolescents, and AdultsDrug Safety, 2003
- Attention-Deficit Hyperactivity Disorders in AdolescenceJournal of Developmental & Behavioral Pediatrics, 1995